Suzette Olu Busola Oyeku, M.D., M.P.H.

Dr. Oyeku is Chief of the Division of Academic General Pediatrics at the Children’s Hospital at Montefiore (CHAM). She is also Professor of Pediatrics at the Albert Einstein College of Medicine. Dr. Oyeku manages the clinical, research, advocacy and educational missions of the division in addition to being responsible for faculty and staff development. 

Dr. Oyeku is a general pediatrician with expertise in health services research, implementation science and the use of quality improvement methods to disseminate effective care strategies and improve care and patient outcomes for children with chronic diseases such as sickle cell disease. Dr. Oyeku’s clinical activities are focused on providing pediatric primary care and inpatient care at Children’s Hospital at Montefiore. Dr. Oyeku also has expertise providing specialized care to children and adolescents with sickle cell disease.

Dr. Oyeku’ s research activities are focused on understanding health services utilization patterns and improving the quality of care for children and adolescents with sickle cell disease. Dr. Oyeku also serves as Medical Director for the Health Resources and Services Administration (HRSA) funded Sickle Cell Disease Treatment Demonstration Program National Coordinating Center at the National Institute for Children’s Health Quality (NICHQ). (https://www.nichq.org/project/sickle-cell-disease-treatment-demonstration-program)

On a regional and national level, Dr. Oyeku has also served on advisory panels and committees focused on sickle cell disease and improving healthcare quality for children and adolescents. She completed a three year term as the Treasurer for the Academic Pediatrics Association, a professional society representing 2,000 child health providers in the US.

She holds a Bachelor’s of Science degree in Biomedicine from the Sophie Davis School of Biomedical Education at the City College of New York. Dr. Oyeku received her medical degree from the New York University School of Medicine and completed her pediatric residency training at the Boston Combined Residency Program in Pediatrics at Boston Medical Center and Boston Children’s Hospital. Dr. Oyeku also completed fellowship training at the Harvard Pediatric Health Services Research Fellowship program at Boston Children’s Hospital. She received her Master’s degree in Public Health with a concentration in clinical effectiveness at the Harvard School of Public Health.  She is also a graduate of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM), a program of Drexel University College of Medicine. Dr. Oyeku is also actively engaged in community education activities and serves as an ordained deacon at Grace Baptist Church in Mount Vernon, NY.

https://www.ncbi.nlm.nih.gov/sites/myncbi/1tImkp-hZ18Ae/bibliography/45399576/public/?sort=date&direction=ascending

Selected List of Publications below:

1. Grosse SD, Boulet SL, Amendah D, Oyeku SO. Administrative Datasets and Health Services Research on Hemoglobinopathies. American Journal of Preventive Medicine. 2010; 38(4S) S557-S567

2. Raphael JL, Mueller BU. Mueller, Kowalkowski MA, Oyeku SO, Shorter Hospitalization Trends Among Children with Sickle Cell Disease. Pediatr Blood Cancer. 2012 Oct; 59(4):679-84. Epub 2012 Jan 4.

3. Wang Y,Kennedy J, Caggana M, Zimmerman R, Thomas S, Berninger J, Harris K, Green NS, Oyeku S, Hulihan M, Grant AM, Grosse SD. Sickle Cell Disease Incidence among Newborns in New York State by Maternal Race/Ethnicity and Nativity. Genet Med. 2013 Mar; 15(3):222-8.Epub 2012 Sep 27.

4.  Oyeku SO, Driscoll MC, Cohen HW, Trachtman R, Pashankar F, Mullen C, Giardina PJ, Velazco N, Racine AD, Green NS.  Parental and Other Factors Associated with Hydroxyurea Use for Pediatric Sickle Cell Disease.Pediatr Blood Cancer. 2013 Apr; 60(4):653-8. Epub 2012 Nov 5

5.Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD; for the BABY HUG Investigators. Hydroxyurea Is Associated With Lower Costs of Care of Young Children With Sickle Cell Anemia. Pediatrics.2013 Sep 2. [Epub ahead of print]

6.Raphael JL, Oyeku SO. Sickle cell disease pain management and the medical home. Hematology Am Soc Hematol Educ Program. 2013; 2013:433-8.

7. Developing a Unified Approach for Sickle Cell Disease. Supplement to American Journal of Preventive Medicine. Guest Editors: Suzette O. Oyeku, Jean L. Raphael, Cynthia H. Cassell and Mary M. Hulihan. Volume 51(1) Supplement 1. July 2016 https://www.ajpmonline.org/issue/S0749-3797(16)X0014-1?code=amepre-site

8. Faro EZ. Wang CJ. Oyeku SO. Quality of Care Indicator Development for Follow-up of Positive Screens for Sickle Cell Disease. American Journal of Preventive Medicine, 2016 Jul; 51(1 Suppl 1):S48-54

9.Frost JR, Cherry RK, Oyeku SO, Faro E, Crosby L, Britto M, Tuchman L, Horn I, Homer C, Jain A. Improving Sickle Cell Transitions of Care Through Health Information Technology. American Journal of Preventive Medicine.  2016 Jul;51(1 Suppl 1): S17-23

10. Homer CJ, Oyeku SO. Sickle Cell Disease: A Roadmap for Getting to Excellence Everywhere. American Journal of Preventive Medicine 2016 Jul;51(1 Suppl 1): S3-4

11. Brown NM,Brown SN, Briggs RD, German M, Belamarich PF, Oyeku SO,  Associations between adverse childhood experiences and ADHD diagnosis and severity. Academic Pediatrics 2017 May - Jun; 17(4):349-355

12.Fuller A, Messito MJ, Mendelsohn AL, Oyeku SO, Gross RS. Prenatal Material Hardships and Infant Regulatory Capacity at 10 Months Old in Low-Income Hispanic Mother-Infant Pairs. Acad Pediatr. 2018 Nov-December; 18(8):897-904; Epub 2018 May 2.

13. Crosby, LE, Walton, A, Shook, LM, Ware, RE, Treadwell, M, Saving, KL, Britto, M, Peugh,         J, McTate, E, Oyeku, S, Nwankwo, C, & Brinkman, WB. Development of a Hydroxyurea Decision Aid for Parents of Children with Sickle Cell Anemia. Journal of   Pediatric Hematology/Oncology. 2018 Jul 23. [Epub ahead of print]